Skip to content

    Yasho Industries Q1 FY27 earnings call

    YASHO
    Chemicals·3 Aug 2026
    Management Summary

    Yasho Industries delivered a strong Q1 FY27, reporting record revenue and significant EBITDA margin expansion driven by volume growth and improved product mix. The company also strengthened its balance sheet with better working capital management and reduced leverage. Strategic capex plans were revised upwards to support future growth, though supply chain and logistics challenges persist.

    Highlights

    5

    • Achieved highest quarterly revenue of ₹308 crores, driven by a 42% increase in volume on a year-on-year basis.

    • EBITDA margin significantly expanded to 24.2% (₹74.42 crores) from 17%, attributed to improved product mix and capacity utilization.

    • Net debt to EBITDA ratio improved to 1.86x as of June 30, 2026, compared with 3.75x at the end of Q4 FY26.

    • Working capital cycle improved from 190 days to 143 days due to better inventory planning and receivables management.

    • Bank loan ratings upgraded from BBB+ to A-, validating financial progress.

    Concerns

    3

    • Facing genuine supply issues on the raw material side.

    • Experiencing challenges with export container booking, leading to longer gestation periods of 3-4 weeks.

    • Acknowledged an uncertain macro environment and war situation.

    Key financials

    Single quarter

    09 metrics
    1. 01Revenue₹308 Cr
    2. 02EBITDA₹74.42 Cr
    3. 03EBITDA Margin24.2%
    4. 04PAT₹36 Cr
    5. 05PAT Margin11.7%

    Segment breakdown

    Export Revenue
    69% Contribution
    Industrial Chemicals
    89% Contribution
    Domestic Market
    10% Growth
    List

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    ₹18.73 crores this quarter · ₹250 crores (FY27) planned

    raised — support additional manufacturing capacities for upcoming product commercialization · expects to raise approximately Rs. 100 crores through borrowings during FY27

    Debt

    1.9x EBITDA

    Guidance & targets

    13
    CategoryTargetPriority
    Revenue
    FY28 Revenue Target
    >₹1,600 crores
    		High
    Revenue
    Annual Revenue Growth
    30-40%
    		High
    Revenue
    New Molecules Revenue (initial)
    ₹50-100 crores
    		Medium
    Revenue
    Pakhajan Phase 1 Revenue (FY28)
    ₹100 crores
    		Medium
    Margin
    EBITDA Margin
    24%
    		High
    Margin
    New Products Margin vs Older Products
    10-12% better
    		High
    Capex
    New CAPEX Asset Turn
    2.5x
    		High
    Capacity
    Pakhajan Phase 1 Operational
    Q1 FY28
    		High
    Capacity
    Pakhajan Phase 2 Operational
    Q4 FY28
    		High
    Capacity
    FY27 Capacity Utilization
    75%
    		High
    Export Mix
    Export Revenue Contribution
    70-75%
    		Medium
    Growth
    Industrial Chemical Growth
    >90%
    		Medium
    Customer Base
    Long-term Customer Base
    >50%
    		High

    What to watch in Q2 FY27

    5

    EBITDA Margin Sustainability

    next quarter
    Current24%
    TargetMaintain 24%

    Why it matters

    Management expressed confidence in sustaining this significantly improved margin, which is a key driver of profitability.

    The Management is confident to sustain the EBITDA margin of its current quarter going forward⏳ on account of improved product mix and better capacity utilization which is backed by commitment from key customers.

    Risks & concerns

    3
    RiskSeverity

    Raw Material Supply Issues

    The company is facing genuine supply issues on the raw material side. — Management acknowledged

    medium

    Export Logistics and Container Booking Challenges

    Difficulty in securing export container bookings is leading to longer gestation periods (3-4 weeks). — Management acknowledged

    medium

    Macroeconomic Uncertainty

    The war situation and uncertain macro environment pose challenges. — Analyst acknowledged

    medium

    Q&A highlights

    8

    “Well, first and foremost, the company achieves a better performance for the selling higher quantity rather than the better realization of the old stock. So, let me clarify that that the company has achieved this with the right product mix, capacity utilization, which has helped us to leverage our all the facilities and not with the stock, what you are concerned. So, that gives us confidence. Number two, we do have some commitment from our marquee customers, which is helping us to confidence to give the guidance that we will be able to maintain in the coming quarters also the similar EBITDA margins.”

    Management explains the drivers behind the significant margin expansion (product mix, capacity utilization, customer commitments) and expresses confidence in its sustainability, which is a key investor concern.

    asked by Meet Katrodiya

    2 min read6 chapters

    Detailed Narrative

    01

    Strong Q1 FY27 Performance & Margin Expansion

    Yasho Industries reported its highest quarterly revenue of ₹308 crores in Q1 FY27, marking a 42% year-on-year volume increase. This strong performance was accompanied by a significant expansion in EBITDA margin from 17% to 24.2%, reaching ₹74.42 crores. Management attributes this to an improved product mix, enhanced capacity utilization exceeding 65%, and disciplined cost management, expressing confidence in sustaining these margins going forward⏳.

    02

    Strategic Capex for Future Growth

    The company has revised its FY27 capital expenditure plan upwards from ₹125 crores to ₹250 crores. This investment is primarily directed towards constructing two new production buildings at its Pakhajan facility, dedicated to manufacturing high-potential industrial chemicals. The expansion will be executed in two phases, with Phase 1 costing ₹100 crores and Phase 2 costing ₹150 crores, expected to be operational by Q1 FY28 and Q4 FY28 respectively. Approximately ₹100 crores of this capex will be funded through borrowings.

    03

    R&D and New Product Development Driving Value

    R&D remains a core focus, with over 50 scientists working on new product development aligned with customer needs. New products launched in the last 12 months have contributed significantly to revenue growth and boast 10-12% better margins than older products. This R&D effort is crucial for attracting new customers and expanding the product portfolio, with initial revenue expectations of ₹50-100 crores from new molecules.

    04

    Export Focus and International Market Expansion

    Exports continue to be a key pillar of the business, contributing approximately 69% of total revenue in Q1 FY27. The company is strengthening its presence in international markets, particularly Asia and Africa, while deepening relationships in existing geographies. Management targets an export mix in the 70-75% range, noting strong growth in the US (post-tariff issues) and Europe.

    05

    Improved Working Capital and Debt Management

    Yasho Industries demonstrated improved financial management, with its working capital cycle reducing significantly from 190 days to 143 days. The net debt to EBITDA ratio improved to 1.86x as of June 30, 2026, down from 3.75x at the end of Q4 FY26. This financial strengthening was recognized by rating agencies, with bank loan ratings upgraded from BBB+ to A-.

    06

    Market Dynamics and Supply Chain Challenges

    While confident in its growth trajectory, management acknowledged current challenges including genuine raw material supply issues and difficulties in securing export container bookings, leading to longer gestation periods. Despite these, the company remains optimistic about the large addressable market and customer demand for diversified supply chains, mitigating concerns about Chinese competition and the long-term impact of EVs on the lube additives segment.

    This is an AI-generated summary of a publicly available earnings call transcript.